It is interesting to note that both homeobox B7 (HOXB7) and BH3 interacting domain death agonist (BID) are also increased in CIN III although to a lesser magnitude (seven and five fold, respectively). The gene discussed is HOXB7; the disease is uterine cervix carcinoma in situ.